Cassava sciences reports full-year 2023 financial results and corporate updates

Austin, texas, feb. 28, 2024 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a biotechnology company focused on alzheimer's disease, today reported financial and operating results for the full year ended december 31, 2023 and presented corporate updates.
SAVA Ratings Summary
SAVA Quant Ranking